Teva Pharmaceuticals resolves bribery case with Israel authorities | The FCPA Blog
US states sue Teva for price-fixing in 'multi-billion dollar fraud' | The Times of Israel
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Stock: Teva Guides To Its First Year Of Growth Since 2017, But There's A Caveat | Investor's Business Daily
Teva Pharmaceuticals Recalls Acute Myeloid Leukemia Drug Over Particulate Matter Contamination - Top Class Actions
Today's News: FBI Raids NY Yeshiva; Layoffs at Israel's Teva Pharmaceuticals; and more - Tablet Magazine
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Outgoing Moderna CMO Lands Seat on Teva Pharmaceuticals Board of Directors | BioSpace
Teva Pharmaceuticals responsible for fueling opioid crisis, New York jury finds - JURIST - News
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva Pharmaceuticals Q4 2016 Earnings
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceutical Industries and opioid settlement: What to know
Do Analysts Expect Teva Pharmaceutical Industries Ltd (TEVA) Stock to Rise After It Has Gained 10.21% in a Month?
Teva Pharmaceuticals - News, Articles etc. - European Pharmaceutical Review
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Teva looks to amp up research collaborations, CEO says
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
